Abstract 3α-Hydroxy-2,19-oxido-5αH-pregnan-20-one was synthesized in 6 steps from the easily available 19-hydroxypregnenolone 3-acetate. The 2,19-oxido bridge was formed in a single step upon spontaneous cyclization and desilylation of a TBDMS protected 19-hydroxy-2α,3α-epoxypregnane. The 4,19-oxido analogue was obtained as a byproduct upon cyclization of the isomeric 3α,4α-epoxide.
Introduction
Endogenous occurring steroids such as 3α-hydroxy-5αH-pregnan-20-one (allopregnanolone, 1) and its 5β-isomer (pregnanolone, 2) are known to interact with the neuroinhibitory GABA A receptor of the central nervous system. [1] [2] [3] Such neurosteroids and their synthetic analogues can,
as a result, demonstrate sedative-hypnotic, anxiolytic or anticonvulsant activities in vivo. In the search of more active, selective and water soluble steroid derivatives, several analogues with improved bioavailability having polar groups at different positions have been developed. 4 Introduction of N or O substituents at the 2β position of allopregnanolone does not change significantly the conformation of ring A and gives rise to active analogues. Thus, minaxolone (3) 5 and Org 21465 (4) 6 are highly effective general anesthetics.
the synthesis and biological activity of several rigid derivatives. The introduction of an oxido bridge between C-2 and C-19 of allopregnanolone, gives rise to 2,19-oxidopregnane 5, with a distorted A ring bent towards the β-face. Besides giving a rigid framework, the oxido-bridge may also mimick the apparently well-tolerated β oxygen substituent at C-2 as in minaxolone (3) . A 4,19-oxidoderivative as 6 gives a similar distortion of ring A but with the oxygenated substituent at C-4. Steroids with 2,19-oxido bridges are also potentially useful drugs in breast cancer therapy as suicide substrates for aromatase, the cytochrome P-450 enzyme involved in the final biosynthetic step in the production of estrogens. 
Results and Discussion
The key step in previous syntheses of substituted analogues of allopregnanolone having polar, electronegative atoms at C-2β, has been the attack of a nucleophile on a 2α,3α-epoxide. 5, 6 Trans diaxial opening of this epoxide accounted for the regioselectivity of the reaction, giving rise to the 3α-OH moiety, a requisite for GABA A receptor activity. The intramolecular version of this process involving a nucleophile attached to C-19, besides being energetically more favorable, would result in the formation of a bridge between positions 2β and 19. Thus, epoxide 7a (or a suitably protected precursor as 7b) was selected as the key intermediate for obtaining the 2,19-oxido-bridged analogue. In a similar way, epoxide 8a should give the 4,19-oxido analogue 6.
The 19-hydroxysteroid 9 was used as starting material. It was obtained from commercially available pregnenolone acetate following essentially the procedure described previously by us for the preparation of the 20-O-acetyloxy analogue. 12 The synthetic sequence is outlined in Reagents and conditions. a) TBDMSCI, imidazole, DMF. b) H 2 , 10 % Pd/C, EtOH. c) i. 10 % NaOH, MeOH; ii. TsCL, py. d) collidine, reflux. e) MCPBA, aqueous Na 2 CO 3 , Cl 2 CH 2 ; ii. Chromatography on silica gel.
Scheme 1
Double bond formation in ring A was carried out in three steps. Thus, compound 11 was deacetylated with base and treated with tosyl chloride in anhydrous pyridine giving 95% of the tosylate 12. Refluxing a solution of 12 in collidine for 3.5 h gave a mixture of the desired ∆ 2 -olefin 13 and the minor ∆ 3 isomer 14 (7:3 ratio by 1 H-NMR; 53% yield from 11). These compounds could not be separated by column chromatography and were used as a mixture in the following step. Treatment of the olefin mixture with m-chloroperbenzoic acid (MCPBA) in the presence of sodium carbonate gave the expected α-epoxides 7b and 8b (from 13 and 14, respectively). 6, 14 The 1 H NMR spectrum of the crude reaction product showed the characteristic resonances for epoxides at 3.1-3.3 ppm and absence of olefinic hydrogens. The isomeric epoxides had different R f on TLC, however when separation was attempted by flash column chromatography an intramolecular attack of the C-19 oxygen occurred, with cleavage of the epoxides and concomitant de-O-silylation (probably catalyzed by the adsorbent). 15 Thus, compounds 5 and 6 were obtained in one step from 13 and 14. The 7:3 ratio of the products was coincident with that of the precursor olefins. Structures of both compounds were established from 1 H and 13 C NMR spectra of 5 and 6 and the correlations in the COSY spectra. Diagnostic signals in the 1 H NMR spectra were those assigned to H-2 (for the major product 5) and H-4 (for the minor analogue, 6) at 4.144 and 3.823 ppm respectively, and their long-range correlations with the C-19 hydrogens displayed in the COSY spectra. Figure 1 shows the AM1 calculated geometries for oxidosteroids 5 and 6 compared to that of allopregnanolone (1) , showing the distortion and bending of ring A. In both steroids the 3α-hydroxyl is displaced upwards and away from its axial orientation resulting in an overall curvature of the molecule towards the β-face. In the 1 H NMR spectrum of 5, H-2 appeared as a double doublet (J = 5.0 and 5.9 Hz), whereas H-4 in 6 was observed as a doublet (J = 4.8 Hz). These data are in accordance with the calculated coupling constants on the above AM1 geometries using the Altona equation (J 2,1α = 0.9 Hz, J 2,1β = 6.9 Hz and J 2,3β = 4.5 Hz for 5 and J 4,5α = 0.5 Hz and J 4,3β = 4.5 Hz for 6). 16 An almost perfect "W arrangement" is predicted between one of the hydrogens at position 19 and H-5α in 5 or H-1α in 6, these are evident in the multiplicity of the H-19 signals and in the correlations observed in the COSY spectra. 
Conclusions
The above procedure may be used to introduce 2,19-and 4,19-oxido bridges in a variety of 5α-H reduced steroids. Furthermore, the change of oxygen by nitrogen or sulfur at C-19, gives easy access to the aza and sulfanyl analogues, respectively.
Experimental Section
General Procedures. Melting points were determined with a Fisher-Johns apparatus and are uncorrected. NMR spectra were recorded on Bruker AC-200 (4. -19-(t-butyldimethylsilyloxy)-5αΗ−pregnan-20-one (11) . To a stirred solution of 3β-acetyloxy-19-hydroxypregn-5-en-20-one (9) (1.00 g, 2.67 mmol) in dry DMF (15 mL) was added imidazole (0.544 g, 8 mmol) and t-butyldimethylsilyl chloride (0.803 g, 5.3 mmol) under a nitrogen atmosphere. After 24 h at 25 ºC the mixture was poured onto HCl (2N) and extracted with dichloromethane. The organic layer was washed with aqueous NaCl and water, dried, filtered and evaporated. The solid residue was recrystallized from 2-propanol to give 10 (1.24g, 95%). 
19-(t-Butyldimethylsilyloxy)-5αH-pregn-2-en-20-one (13) and 19-(t-butyldimethyl silyloxy)-5αH-pregn-3-en-20-one (14).
To a stirred solution of 5α-steroid 11 (0.900 g, 1.83 mmol) in methanol (160 ml) was added an aqueous solution of NaOH (10%, 3.7 mL) at 25 ºC under nitrogen. After 2 h the mixture was neutralized with HCl (1N), concentrated and extracted with dichloromethane. The organic layer was washed with a saturated solution of NaCl, dried (Na 2 SO 4 ) and evaporated to give 3β- To the mixture of olefins 13 and 14 (0.100 g, 0.23 mmol) obtained above, was added dichloromethane (6 mL), water (4 mL), Na 2 CO 3 (0.100 g) and 3-chloroperoxybenzoic acid (0.104 g, 0.603 mmol) and vigorously stirred at room temperature for 5 h. The mixture was diluted with dichloromethane (10 ml) and the aqueous layer was extracted with dichloromethane. The combined organic extracts were washed with Na 2 SO 3 (5%), saturated aqueous NaHCO 3 
